1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CTI-PGT302, CWRU-CTI-1503, NCT00054184
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CTI-PGT304, NCT00054197
|
|
3.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CTI-PGT303, NCT00054210
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CTI-PGT305, CTI-PIONEER, NCT00269828
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: Not specified Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-01024, CTI-1071, NCI-G01-1947, NCT00017017
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-0186C, NCT00045682
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PGT201, NCT00069901
|
|
8.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N0437, N0437, NCT00265733
|
|
9.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: PCa-X-02, 03-0192-05, NCT00446836
|
|
10.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: OHSU-2656, SOL-06048-L, NCT00459810
|
|
11.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: D-0433, NCT00487669
|
|
12.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-9914, NCT00060359
|
|
13.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 2005-0133, NCT00270907
|
|
14.
|
Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 3C-07-3, NCT00598247
|